Literature DB >> 16808060

Cetuximab approved by FDA for treatment of head and neck squamous cell cancer.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808060

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  14 in total

1.  Treatment trends in head and neck cancer: Surveillance, Epidemiology, and End Results (SEER) Patterns of Care analysis.

Authors:  Jennifer A Schlichting; Nitin A Pagedar; Catherine Chioreso; Charles F Lynch; Mary E Charlton
Journal:  Cancer Causes Control       Date:  2019-05-22       Impact factor: 2.506

Review 2.  Monitoring the immune competence of cancer patients to predict outcome.

Authors:  Serena Chang; Holbrook Kohrt; Holden T Maecker
Journal:  Cancer Immunol Immunother       Date:  2014-02-01       Impact factor: 6.968

3.  Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.

Authors:  C Cripps; E Winquist; M C Devries; D Stys-Norman; R Gilbert
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

Review 4.  Data-driven methods to discover molecular determinants of serious adverse drug events.

Authors:  A P Chiang; A J Butte
Journal:  Clin Pharmacol Ther       Date:  2009-01-28       Impact factor: 6.875

5.  Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept.

Authors:  Tomislav Dragovich; Christopher Campen
Journal:  J Oncol       Date:  2009-07-14       Impact factor: 4.375

Review 6.  Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.

Authors:  Rachel Shukrun; Naomi Pode Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2013-06-13       Impact factor: 3.714

Review 7.  Rash from EGFR inhibitors: opportunities and challenges for palliation.

Authors:  Benjamin M Solomon; Aminah Jatoi
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

8.  Anaphylactic reactions to oligosaccharides in red meat: a syndrome in evolution.

Authors:  Hana Saleh; Scott Embry; Andromeda Nauli; Seif Atyia; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2012-03-07

Review 9.  Current Prospects of Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma.

Authors:  K Devaraja
Journal:  Pharmaceut Med       Date:  2019-08

10.  Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.

Authors:  Shih-Heng Tseng; Min-Yuan Chou; I-Ming Chu
Journal:  Int J Nanomedicine       Date:  2015-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.